Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
von Hippel-Lindau Disease | 16 | 2024 | 151 | 3.040 |
Why?
|
Carcinoma, Renal Cell | 25 | 2023 | 3218 | 2.050 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 21 | 2024 | 307 | 2.000 |
Why?
|
Kidney Neoplasms | 25 | 2023 | 4312 | 1.940 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 12 | 2024 | 1137 | 1.850 |
Why?
|
Tumor Suppressor Proteins | 19 | 2018 | 2802 | 1.690 |
Why?
|
Ligases | 13 | 2001 | 332 | 1.170 |
Why?
|
Hemangioblastoma | 3 | 2024 | 63 | 1.020 |
Why?
|
Birt-Hogg-Dube Syndrome | 3 | 2022 | 40 | 0.920 |
Why?
|
Ubiquitin-Protein Ligases | 14 | 2004 | 1888 | 0.780 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2023 | 243 | 0.720 |
Why?
|
Glutamine | 5 | 2021 | 576 | 0.660 |
Why?
|
Genes, Tumor Suppressor | 13 | 2001 | 1055 | 0.640 |
Why?
|
Polysaccharides | 2 | 2015 | 1016 | 0.610 |
Why?
|
Clusterin | 2 | 2015 | 71 | 0.590 |
Why?
|
Glutaminase | 1 | 2017 | 33 | 0.570 |
Why?
|
rab GTP-Binding Proteins | 1 | 2017 | 251 | 0.510 |
Why?
|
Proto-Oncogene Proteins | 3 | 2018 | 4496 | 0.510 |
Why?
|
Zebrafish | 6 | 2024 | 2997 | 0.500 |
Why?
|
Hydrazones | 1 | 2015 | 102 | 0.480 |
Why?
|
Germ-Line Mutation | 5 | 2023 | 1842 | 0.480 |
Why?
|
Pheochromocytoma | 4 | 2006 | 328 | 0.480 |
Why?
|
Phthalazines | 1 | 2017 | 382 | 0.470 |
Why?
|
Zebrafish Proteins | 3 | 2024 | 1006 | 0.460 |
Why?
|
G2 Phase | 2 | 2013 | 133 | 0.450 |
Why?
|
Glycopeptides | 1 | 2015 | 220 | 0.450 |
Why?
|
Citrates | 1 | 2013 | 135 | 0.420 |
Why?
|
Protein Biosynthesis | 3 | 2010 | 2104 | 0.420 |
Why?
|
Estrone | 1 | 2013 | 232 | 0.410 |
Why?
|
Sulfones | 1 | 2015 | 447 | 0.410 |
Why?
|
5' Untranslated Regions | 2 | 2015 | 255 | 0.400 |
Why?
|
Cell Hypoxia | 8 | 2015 | 657 | 0.390 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2024 | 259 | 0.370 |
Why?
|
Response Elements | 2 | 2010 | 308 | 0.370 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2010 | 37 | 0.350 |
Why?
|
Prostaglandin D2 | 2 | 2010 | 108 | 0.350 |
Why?
|
Proteins | 11 | 2000 | 6029 | 0.320 |
Why?
|
Cell Division | 2 | 2013 | 4463 | 0.290 |
Why?
|
Glycoproteins | 1 | 2014 | 2208 | 0.280 |
Why?
|
Glucose Transporter Type 1 | 4 | 2021 | 186 | 0.280 |
Why?
|
Piperazines | 1 | 2017 | 2525 | 0.270 |
Why?
|
Kidney Diseases | 1 | 2015 | 2093 | 0.240 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 16932 | 0.240 |
Why?
|
Epidermal Growth Factor | 2 | 2021 | 695 | 0.240 |
Why?
|
Proteome | 1 | 2014 | 1855 | 0.230 |
Why?
|
Kidney | 6 | 2023 | 7064 | 0.230 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2008 | 733 | 0.220 |
Why?
|
Reactive Oxygen Species | 2 | 2024 | 2138 | 0.220 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2024 | 929 | 0.220 |
Why?
|
Oxygen | 4 | 2015 | 4193 | 0.220 |
Why?
|
Small Molecule Libraries | 1 | 2008 | 734 | 0.210 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2015 | 620 | 0.210 |
Why?
|
Endothelial Growth Factors | 4 | 1998 | 673 | 0.210 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2002 | 40 | 0.200 |
Why?
|
Lymphokines | 5 | 1998 | 927 | 0.200 |
Why?
|
Ketoglutaric Acids | 2 | 2020 | 75 | 0.200 |
Why?
|
Nasal Provocation Tests | 3 | 1991 | 9 | 0.200 |
Why?
|
Gene Expression Regulation | 5 | 2015 | 11902 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8512 | 0.190 |
Why?
|
Adenoma, Oxyphilic | 1 | 2003 | 148 | 0.190 |
Why?
|
Indenes | 1 | 2021 | 58 | 0.190 |
Why?
|
Chromatography, Liquid | 3 | 2014 | 987 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor A | 9 | 2015 | 3484 | 0.180 |
Why?
|
Basophils | 4 | 1992 | 404 | 0.180 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3583 | 0.180 |
Why?
|
Proteomics | 1 | 2014 | 3817 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1796 | 0.180 |
Why?
|
Iron | 1 | 2008 | 1786 | 0.180 |
Why?
|
Central Nervous System Neoplasms | 2 | 2024 | 916 | 0.170 |
Why?
|
Mice, Nude | 6 | 2020 | 3607 | 0.170 |
Why?
|
Skin Pigmentation | 1 | 2021 | 277 | 0.160 |
Why?
|
Central Nervous System | 1 | 2006 | 1334 | 0.160 |
Why?
|
Nitrogen | 1 | 2020 | 350 | 0.160 |
Why?
|
Humans | 64 | 2024 | 760613 | 0.160 |
Why?
|
Tandem Mass Spectrometry | 2 | 2015 | 1189 | 0.160 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 495 | 0.150 |
Why?
|
Animals | 24 | 2024 | 167960 | 0.150 |
Why?
|
Neovascularization, Pathologic | 6 | 2015 | 2640 | 0.150 |
Why?
|
Larva | 2 | 2016 | 509 | 0.140 |
Why?
|
Nasal Mucosa | 2 | 1992 | 412 | 0.140 |
Why?
|
Mitochondrial Diseases | 1 | 2020 | 340 | 0.140 |
Why?
|
Cytoplasmic Vesicles | 1 | 2016 | 73 | 0.130 |
Why?
|
Oxidation-Reduction | 4 | 2021 | 2222 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1078 | 0.130 |
Why?
|
Nephrectomy | 2 | 2014 | 1016 | 0.130 |
Why?
|
Glycogen | 1 | 2016 | 251 | 0.130 |
Why?
|
RNA, Messenger | 7 | 2021 | 12762 | 0.130 |
Why?
|
Glutamates | 1 | 2017 | 391 | 0.130 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 2015 | 23 | 0.130 |
Why?
|
Histamine Release | 3 | 1992 | 136 | 0.130 |
Why?
|
Fibronectins | 2 | 1998 | 722 | 0.130 |
Why?
|
Schizosaccharomyces | 1 | 2017 | 237 | 0.120 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 428 | 0.120 |
Why?
|
Citric Acid Cycle | 2 | 2013 | 230 | 0.120 |
Why?
|
Age of Onset | 2 | 2021 | 3302 | 0.120 |
Why?
|
Endosomes | 1 | 2017 | 519 | 0.120 |
Why?
|
Technology Assessment, Biomedical | 1 | 2017 | 306 | 0.120 |
Why?
|
Kidney Tubules | 1 | 2016 | 449 | 0.120 |
Why?
|
Microscopy, Electron | 1 | 2018 | 2558 | 0.120 |
Why?
|
Cell Fractionation | 1 | 2014 | 251 | 0.120 |
Why?
|
Polycythemia | 1 | 2015 | 125 | 0.120 |
Why?
|
Trans-Activators | 1 | 2004 | 2860 | 0.120 |
Why?
|
Chromatography, Affinity | 1 | 2015 | 534 | 0.110 |
Why?
|
Tumor Cells, Cultured | 7 | 2021 | 6130 | 0.110 |
Why?
|
Sequence Deletion | 1 | 2018 | 1493 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1728 | 0.110 |
Why?
|
Transcription Factors | 9 | 2013 | 12102 | 0.110 |
Why?
|
Vascular Endothelial Growth Factors | 4 | 1998 | 748 | 0.100 |
Why?
|
Carboxylic Acids | 1 | 2013 | 90 | 0.100 |
Why?
|
Histamine | 3 | 1991 | 498 | 0.100 |
Why?
|
Paraganglioma | 2 | 2006 | 142 | 0.100 |
Why?
|
Glucose | 3 | 2021 | 4350 | 0.100 |
Why?
|
Cell Proliferation | 5 | 2021 | 10442 | 0.100 |
Why?
|
Hypersensitivity, Delayed | 2 | 1990 | 490 | 0.100 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 352 | 0.100 |
Why?
|
Carbon Isotopes | 1 | 2013 | 459 | 0.100 |
Why?
|
NADP | 1 | 2013 | 223 | 0.100 |
Why?
|
Epithelial Cells | 3 | 2021 | 3663 | 0.100 |
Why?
|
Transforming Growth Factor beta | 2 | 2015 | 1959 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2010 | 2058 | 0.100 |
Why?
|
Exons | 1 | 2018 | 2389 | 0.100 |
Why?
|
Phenotype | 4 | 2016 | 16548 | 0.100 |
Why?
|
Extracellular Fluid | 1 | 2013 | 165 | 0.100 |
Why?
|
Embryo, Nonmammalian | 1 | 2015 | 900 | 0.100 |
Why?
|
Embryonic Development | 1 | 2016 | 716 | 0.100 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1544 | 0.100 |
Why?
|
Kinins | 1 | 1990 | 14 | 0.090 |
Why?
|
Mutation | 9 | 2017 | 29957 | 0.090 |
Why?
|
Mice | 12 | 2021 | 81209 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2003 | 2829 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 1998 | 1726 | 0.090 |
Why?
|
Peptide Hydrolases | 2 | 1990 | 623 | 0.090 |
Why?
|
Carbonic Anhydrases | 1 | 2010 | 109 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1 | 3 | 2006 | 193 | 0.090 |
Why?
|
Lipogenesis | 1 | 2011 | 210 | 0.090 |
Why?
|
Peptide Synthases | 2 | 2001 | 80 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2015 | 1516 | 0.080 |
Why?
|
Drug Approval | 1 | 2017 | 816 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2015 | 1347 | 0.080 |
Why?
|
Postoperative Period | 1 | 2014 | 1818 | 0.080 |
Why?
|
Retinal Vessels | 1 | 2015 | 836 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5349 | 0.080 |
Why?
|
Iron-Regulatory Proteins | 1 | 2008 | 30 | 0.080 |
Why?
|
Respiratory Hypersensitivity | 1 | 1990 | 272 | 0.080 |
Why?
|
NAD | 1 | 2013 | 609 | 0.080 |
Why?
|
Immunoglobulin E | 2 | 1992 | 1484 | 0.080 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2011 | 302 | 0.080 |
Why?
|
Dimerization | 1 | 2010 | 891 | 0.080 |
Why?
|
Humidity | 2 | 1988 | 205 | 0.080 |
Why?
|
Iron Chelating Agents | 1 | 2008 | 138 | 0.070 |
Why?
|
Hypersensitivity, Immediate | 1 | 1990 | 345 | 0.070 |
Why?
|
Cullin Proteins | 2 | 1999 | 178 | 0.070 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 522 | 0.070 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10826 | 0.070 |
Why?
|
Sirtuins | 1 | 2010 | 320 | 0.070 |
Why?
|
Protein Stability | 1 | 2008 | 566 | 0.070 |
Why?
|
RNA Stability | 1 | 2008 | 333 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13627 | 0.070 |
Why?
|
Neuroendocrine Tumors | 2 | 2024 | 650 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2024 | 7593 | 0.070 |
Why?
|
Antigens | 1 | 1992 | 1447 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2013 | 0.070 |
Why?
|
DNA Damage | 3 | 2024 | 2442 | 0.070 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2008 | 345 | 0.070 |
Why?
|
Eosinophils | 1 | 1991 | 944 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18137 | 0.070 |
Why?
|
Hypesthesia | 1 | 2006 | 107 | 0.070 |
Why?
|
Protein Binding | 3 | 2008 | 9335 | 0.070 |
Why?
|
Monosaccharide Transport Proteins | 2 | 1998 | 440 | 0.060 |
Why?
|
Melanoma | 1 | 2024 | 5697 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2008 | 1832 | 0.060 |
Why?
|
Cell Line | 6 | 2021 | 15620 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22020 | 0.060 |
Why?
|
Protein Kinases | 2 | 2008 | 1612 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9530 | 0.060 |
Why?
|
Cold Temperature | 1 | 1988 | 780 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 675 | 0.060 |
Why?
|
Cystadenoma, Serous | 1 | 2024 | 100 | 0.060 |
Why?
|
Endothelial Cells | 2 | 2008 | 3539 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 2013 | 1710 | 0.060 |
Why?
|
Drosophila Proteins | 1 | 2013 | 1699 | 0.050 |
Why?
|
Tuberous Sclerosis | 2 | 2003 | 1030 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11152 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2004 | 426 | 0.050 |
Why?
|
Female | 11 | 2024 | 391246 | 0.050 |
Why?
|
Fibroblasts | 1 | 2013 | 4089 | 0.050 |
Why?
|
SKP Cullin F-Box Protein Ligases | 2 | 2001 | 174 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9497 | 0.050 |
Why?
|
Colonic Neoplasms | 2 | 2005 | 2526 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3765 | 0.050 |
Why?
|
Male | 13 | 2024 | 359718 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2005 | 698 | 0.050 |
Why?
|
Phosphorylation | 1 | 2013 | 8311 | 0.050 |
Why?
|
Pyrroles | 1 | 2008 | 1137 | 0.050 |
Why?
|
Respiration | 1 | 1988 | 1654 | 0.050 |
Why?
|
Melanosomes | 1 | 2021 | 33 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2012 | 3844 | 0.050 |
Why?
|
Monophenol Monooxygenase | 1 | 2021 | 74 | 0.050 |
Why?
|
Transaminases | 1 | 2022 | 196 | 0.050 |
Why?
|
Liver | 3 | 2015 | 7510 | 0.050 |
Why?
|
Neoplasms | 3 | 2020 | 22075 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2022 | 3725 | 0.050 |
Why?
|
Young Adult | 2 | 2024 | 58748 | 0.050 |
Why?
|
Hand | 1 | 2006 | 903 | 0.050 |
Why?
|
Adult | 8 | 2024 | 220007 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1547 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12968 | 0.040 |
Why?
|
Indoles | 1 | 2008 | 1829 | 0.040 |
Why?
|
Mammary Glands, Human | 1 | 2021 | 203 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2873 | 0.040 |
Why?
|
Cell Movement | 1 | 2012 | 5206 | 0.040 |
Why?
|
Signal Transduction | 2 | 2017 | 23374 | 0.040 |
Why?
|
Models, Biological | 2 | 2013 | 9468 | 0.040 |
Why?
|
Middle Aged | 7 | 2024 | 220359 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20080 | 0.040 |
Why?
|
Spermatocele | 1 | 2018 | 10 | 0.040 |
Why?
|
Anilides | 1 | 2022 | 409 | 0.040 |
Why?
|
Skin Tests | 2 | 1991 | 637 | 0.040 |
Why?
|
Kidney Diseases, Cystic | 1 | 2000 | 183 | 0.040 |
Why?
|
Pedigree | 1 | 2006 | 4578 | 0.040 |
Why?
|
Genetic Testing | 2 | 2021 | 3531 | 0.040 |
Why?
|
Varicocele | 1 | 2018 | 78 | 0.040 |
Why?
|
Neutrophils | 1 | 1991 | 3767 | 0.040 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 1998 | 100 | 0.040 |
Why?
|
Testis | 2 | 2018 | 794 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2008 | 2049 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3759 | 0.040 |
Why?
|
Melanocytes | 1 | 2021 | 512 | 0.040 |
Why?
|
Molecular Sequence Data | 6 | 2010 | 17624 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 586 | 0.040 |
Why?
|
Ubiquitins | 1 | 1999 | 370 | 0.040 |
Why?
|
F-Box Proteins | 1 | 1999 | 202 | 0.040 |
Why?
|
Immunotherapy | 2 | 2004 | 4642 | 0.040 |
Why?
|
Amino Acid Sequence | 5 | 2010 | 13451 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2021 | 1456 | 0.040 |
Why?
|
Aged | 3 | 2024 | 169143 | 0.040 |
Why?
|
Neurofibromatosis 1 | 1 | 2002 | 560 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 869 | 0.030 |
Why?
|
Nuclear Proteins | 3 | 2004 | 5795 | 0.030 |
Why?
|
Cell Count | 2 | 1991 | 1835 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3420 | 0.030 |
Why?
|
Ubiquitin | 1 | 2021 | 838 | 0.030 |
Why?
|
Molecular Weight | 1 | 1998 | 2186 | 0.030 |
Why?
|
Gene Deletion | 1 | 2004 | 2668 | 0.030 |
Why?
|
Base Sequence | 2 | 1998 | 12444 | 0.030 |
Why?
|
Lactic Acid | 1 | 2021 | 1134 | 0.030 |
Why?
|
England | 1 | 2017 | 526 | 0.030 |
Why?
|
France | 1 | 2017 | 511 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2021 | 1167 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1996 | 256 | 0.030 |
Why?
|
Cytosol | 1 | 1998 | 887 | 0.030 |
Why?
|
Peptide Mapping | 1 | 1995 | 262 | 0.030 |
Why?
|
Diarrhea | 1 | 2022 | 1319 | 0.030 |
Why?
|
Carrier Proteins | 2 | 1999 | 4938 | 0.030 |
Why?
|
RNA Interference | 1 | 2004 | 2846 | 0.030 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2015 | 110 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 1998 | 1754 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1313 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1995 | 384 | 0.030 |
Why?
|
Carcinoma | 2 | 1997 | 2331 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4169 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1544 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.030 |
Why?
|
Cytoplasm | 2 | 1997 | 1516 | 0.030 |
Why?
|
DNA Primers | 1 | 1998 | 2818 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1996 | 617 | 0.030 |
Why?
|
Immunity, Cellular | 2 | 1991 | 1557 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1995 | 1543 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21029 | 0.030 |
Why?
|
Incidental Findings | 1 | 2018 | 698 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3280 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 3 | 1999 | 3734 | 0.030 |
Why?
|
Transfection | 2 | 1998 | 5781 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1290 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1388 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9406 | 0.030 |
Why?
|
Beer | 1 | 1992 | 134 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 283 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 1998 | 1674 | 0.030 |
Why?
|
Anemia | 1 | 2021 | 1511 | 0.020 |
Why?
|
Breast | 1 | 2021 | 1963 | 0.020 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2011 | 38 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 2012 | 327 | 0.020 |
Why?
|
Acetyl Coenzyme A | 1 | 2011 | 75 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3113 | 0.020 |
Why?
|
Alcoholic Intoxication | 1 | 1992 | 174 | 0.020 |
Why?
|
Palmitic Acid | 1 | 2011 | 149 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1995 | 2471 | 0.020 |
Why?
|
Kinetics | 1 | 1998 | 6377 | 0.020 |
Why?
|
Pollen | 1 | 1990 | 81 | 0.020 |
Why?
|
Nucleotides | 1 | 2013 | 450 | 0.020 |
Why?
|
Glutathione | 1 | 2013 | 582 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17790 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2015 | 18955 | 0.020 |
Why?
|
Pyridines | 1 | 2022 | 2879 | 0.020 |
Why?
|
Population Surveillance | 1 | 2020 | 2608 | 0.020 |
Why?
|
Models, Genetic | 1 | 2000 | 3442 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 1999 | 3448 | 0.020 |
Why?
|
Limit of Detection | 1 | 2010 | 280 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1991 | 356 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1854 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1998 | 2907 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 87809 | 0.020 |
Why?
|
Cell Respiration | 1 | 2010 | 202 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1096 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2013 | 670 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2008 | 36286 | 0.020 |
Why?
|
Antibody Specificity | 1 | 1991 | 1060 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 598 | 0.020 |
Why?
|
Genes, ras | 2 | 2004 | 654 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6538 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9591 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1677 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1617 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 877 | 0.020 |
Why?
|
Brain | 1 | 2015 | 26951 | 0.020 |
Why?
|
Systems Biology | 1 | 2012 | 482 | 0.020 |
Why?
|
Carbon | 1 | 2011 | 669 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3601 | 0.020 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 1988 | 104 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1988 | 292 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2011 | 679 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 979 | 0.020 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 1987 | 59 | 0.020 |
Why?
|
Nose | 2 | 1989 | 519 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1603 | 0.020 |
Why?
|
Luciferases | 1 | 2008 | 716 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8595 | 0.020 |
Why?
|
Glycolysis | 1 | 2010 | 828 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2008 | 480 | 0.020 |
Why?
|
Ultrasonography | 1 | 2018 | 5961 | 0.020 |
Why?
|
Genotype | 1 | 2000 | 12957 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 806 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2013 | 1398 | 0.020 |
Why?
|
Mast Cells | 1 | 1992 | 1390 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13505 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10185 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2008 | 1529 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1996 | 2299 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 13982 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3618 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 29661 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1347 | 0.010 |
Why?
|
Allergens | 1 | 1991 | 1402 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2192 | 0.010 |
Why?
|
Cell Death | 1 | 2008 | 1671 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1992 | 2282 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 732 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15790 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2013 | 3106 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11713 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2788 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5039 | 0.010 |
Why?
|
Rhinitis | 1 | 1988 | 746 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5251 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39262 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1992 | 1941 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24102 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 1999 | 53 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 2004 | 5782 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2001 | 8985 | 0.010 |
Why?
|
Time Factors | 3 | 1991 | 40139 | 0.010 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 1999 | 90 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1991 | 4542 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4354 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41337 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2011 | 4550 | 0.010 |
Why?
|
Hypersensitivity | 1 | 1987 | 1155 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2008 | 5869 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 64981 | 0.010 |
Why?
|
Spheroids, Cellular | 1 | 1998 | 329 | 0.010 |
Why?
|
Double-Blind Method | 1 | 1991 | 12427 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4122 | 0.010 |
Why?
|
Second Messenger Systems | 1 | 1997 | 202 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8552 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1998 | 1433 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13308 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 911 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1999 | 2176 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14374 | 0.010 |
Why?
|
Uterus | 1 | 1997 | 651 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2262 | 0.010 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 1992 | 65 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1605 | 0.010 |
Why?
|
Metals | 1 | 1997 | 736 | 0.010 |
Why?
|
Muscles | 1 | 1997 | 1581 | 0.010 |
Why?
|
Ibuprofen | 1 | 1992 | 229 | 0.010 |
Why?
|
Cell Cycle | 1 | 1999 | 2935 | 0.010 |
Why?
|
Urinary Bladder | 1 | 1997 | 1166 | 0.010 |
Why?
|
Point Mutation | 1 | 1995 | 1594 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1998 | 6216 | 0.010 |
Why?
|
Colon | 1 | 1997 | 1788 | 0.010 |
Why?
|
United States | 1 | 2017 | 72448 | 0.000 |
Why?
|
Prostate | 1 | 1997 | 1793 | 0.000 |
Why?
|
Saccharomyces cerevisiae | 1 | 1999 | 2698 | 0.000 |
Why?
|
Binding Sites | 1 | 1997 | 6048 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8158 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13262 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1997 | 11070 | 0.000 |
Why?
|
Rats | 1 | 1999 | 23709 | 0.000 |
Why?
|
Temperature | 1 | 1988 | 2221 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1998 | 11481 | 0.000 |
Why?
|
Aspirin | 1 | 1992 | 3364 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1989 | 1869 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1987 | 2145 | 0.000 |
Why?
|
Skin | 1 | 1989 | 4466 | 0.000 |
Why?
|
Environmental Exposure | 1 | 1988 | 4412 | 0.000 |
Why?
|